Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 28;16(1):152.
doi: 10.3390/cancers16010152.

Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?

Affiliations
Review

Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?

Marta Łukaszewicz-Zając et al. Cancers (Basel). .

Abstract

Despite recent() improvements in diagnostic ability() and treatment() strategies for patients() with neoplastic disease(), gastrointestinal (GI) cancers(), such() as colorectal, gastric, pancreatic, and oesophageal cancers(), are still common() malignancies and the leading() cause() of cancer() deaths worldwide(), with a high frequency of recurrence and metastasis as well as poor patient() prognosis. There is a link() between the secretion of proteolytic enzymes that degrade the extracellular matrix and the pathogenesis of GI tumours. Recent() findings have focused() on the potential() significance() of selected claudins (CLDNs) in the pathogenesis and prognosis of GI cancers(). Tight junctions (TJs) have been proven to play an important role() in maintaining cell() polarity and permeability. A number of authors have recently() revealed that TJ proteins, particularly() selected CLDNs, are related() to inflammation and the development() of various tumours, including GI malignancies. This review() presents general() characteristics and the involvement() of selected CLDNs in the progression() of GI malignancies, with a focus() on the potential() application() of these proteins in the diagnosis() and prognosis of colorectal cancer() (CRC), gastric cancer() (GC), pancreatic cancer() (PC), and oesophageal cancer() (EC). Our review() indicates that selected CLDNs, particularly() CLDN1, 2, 4, 7, and 18, play a significant() role() in the development() of GI tumours and in patient() prognosis. Furthermore, selected CLDNs may be of value() in the design() of therapeutic() strategies for the treatment() of recurrent tumours.

Keywords: biomarker; claudins; gastrointestinal tumours.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structure of claudins (CLDNs) [1,2,3,4,5,17,18,19,25].
Figure 2
Figure 2
Role of claudins (CLDNs) in tumour development [31,32,33,34,35].

Similar articles

Cited by

References

    1. Kwon M.J. Emerging Roles of Claudins in Human Cancer. Int. J. Mol. Sci. 2013;14:18148–18180. doi: 10.3390/ijms140918148. - DOI - PMC - PubMed
    1. Kaufmann R., Piontek J., Grüll F., Kirchgessner M., Rossa J., Wolburg H., Blasig I.E., Cremer C. Visualization and Quantitative Analysis of Reconstituted Tight Junctions Using Localization Microscopy. PLoS ONE. 2012;7:e31128. - PMC - PubMed
    1. Hennessy B.T., Gonzalez-Angulo A.M., Stemke-Hale K., Gilcrease M.Z., Krishnamurthy S., Lee J.S., Fridlyand J., Sahin A., Agarwal R., Joy C., et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 2009;69:4116–4124. doi: 10.1158/0008-5472.CAN-08-3441. - DOI - PMC - PubMed
    1. Turksen K. Claudins and cancer stem cells. Stem Cell Rev. 2011;7:797–798. doi: 10.1007/s12015-011-9267-1. - DOI - PubMed
    1. Günzel D., Stuiver M., Kausalya P.J., Haisch L., Krug S.M., Rosenthal R., Meij I.C., Hunziker W., Fromm M., Müller D. Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J. Cell Sci. 2009;122:1507–1517. doi: 10.1242/jcs.040113. - DOI - PubMed

LinkOut - more resources